Home
/
BioScience Health Innovations, Inc.
/
Financials
/
Quarterly
BioScience Health Innovations, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that BioScience Health Innovations, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$1.13M
Oct 27, 2025
Q2
2025
Jun 30, 2025
$1.76M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$1.23M
May 8, 2025
Q3
2025
Sep 30, 2024
$573.0K
Oct 27, 2025
Q2
2025
Jun 30, 2024
$384.2K
Aug 7, 2025
Q1
2025
Mar 31, 2024
$277.6K
May 8, 2025
Q3
2024
Sep 30, 2023
$192.2K
Oct 28, 2024
Q2
2024
Jun 30, 2023
$69.5K
Jul 30, 2024
Q1
2024
Mar 31, 2023
$32.3K
May 3, 2024
Q2
2023
Feb 28, 2023
$0
May 17, 2024
Q1
2023
Nov 30, 2022
$0
Jan 13, 2023
Q3
2023
Sep 30, 2022
$19.7K
Oct 31, 2023
Q2
2023
Jun 30, 2022
$8.0K
Aug 11, 2023
Q3
2022
May 31, 2022
$0
Jul 13, 2022
Q1
2023
Mar 31, 2022
$279
May 15, 2023
Q2
2023
Feb 28, 2022
$0
May 17, 2024
Q1
2023
Nov 30, 2021
$0
Jan 13, 2023
Q3
2022
May 31, 2021
$0
Jul 13, 2022
Q2
2022
Feb 28, 2021
$0
Apr 14, 2022
Q1
2022
Nov 30, 2020
$0
Jan 14, 2022
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.8K)
Oct 27, 2025
Q2
2025
Jun 30, 2025
$457.7K
Aug 7, 2025
Q3
2025
Jun 30, 2025
$457.7K
Oct 27, 2025
Q2
2025
Mar 31, 2025
$426.8K
Aug 7, 2025
Q3
2025
Mar 31, 2025
$426.8K
Oct 27, 2025
Q1
2025
Mar 31, 2025
$426.8K
May 8, 2025
Q3
2025
Sep 30, 2024
$56.2K
Oct 27, 2025
Q3
2025
Jun 30, 2024
$74.2K
Oct 27, 2025
Q2
2025
Jun 30, 2024
$74.2K
Aug 7, 2025
Q1
2025
Mar 31, 2024
($53.4K)
May 8, 2025
Q2
2025
Mar 31, 2024
($53.4K)
Aug 7, 2025
Q3
2025
Mar 31, 2024
($53.4K)
Oct 27, 2025
Q3
2024
Sep 30, 2023
($57.1K)
Oct 28, 2024
Q2
2024
Jun 30, 2023
($85.3K)
Jul 30, 2024
Q3
2024
Jun 30, 2023
($85.3K)
Oct 28, 2024
Q3
2024
Mar 31, 2023
($70.7K)
Oct 28, 2024
Q2
2024
Mar 31, 2023
($70.7K)
Jul 30, 2024
Q1
2024
Mar 31, 2023
($70.7K)
May 3, 2024
Q2
2023
Feb 28, 2023
($20.0K)
May 17, 2024
Q1
2023
Nov 30, 2022
($28.9K)
Jan 13, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($8.8K)
Oct 27, 2025
Q2
2025
Jun 30, 2025
$457.7K
Aug 7, 2025
Q1
2025
Mar 31, 2025
$426.8K
May 8, 2025
Q3
2025
Sep 30, 2024
$56.2K
Oct 27, 2025
Q2
2025
Jun 30, 2024
$74.2K
Aug 7, 2025
Q1
2025
Mar 31, 2024
($53.4K)
May 8, 2025
Q3
2024
Sep 30, 2023
($57.1K)
Oct 28, 2024
Q2
2024
Jun 30, 2023
($85.3K)
Jul 30, 2024
Q1
2024
Mar 31, 2023
($70.7K)
May 3, 2024
Q2
2023
Feb 28, 2023
($20.0K)
May 17, 2024
Q1
2023
Nov 30, 2022
($28.9K)
Jan 13, 2023
Q3
2023
Sep 30, 2022
($84.7K)
Oct 31, 2023
Q2
2023
Jun 30, 2022
($1.9K)
Aug 11, 2023
Q3
2022
May 31, 2022
($47.9K)
Jul 13, 2022
Q1
2023
Mar 31, 2022
($4.2K)
May 15, 2023
Q2
2023
Feb 28, 2022
($26.2K)
May 17, 2024
Q1
2023
Nov 30, 2021
($14.1K)
Jan 13, 2023
Q3
2022
May 31, 2021
($3.2K)
Jul 13, 2022
Q2
2022
Feb 28, 2021
($12.7K)
Apr 14, 2022
Q1
2022
Nov 30, 2020
($5.6K)
Jan 14, 2022